Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-06-21T19:53:32.402Z Has data issue: false hasContentIssue false
  • English
  • Français

Anterior pituitary hormone secretion in chronic schizophrenia – an approach to neurohumoral mechanisms

Published online by Cambridge University Press:  09 July 2009

Eve C. Johnstone ,
T. J. Crow  and
K. Mashiter
Eve C. Johnstone*
Affiliation:
Division of Psychiatry, Clinical Research Centre, Harrow and the Endocrine Unit, Department of Medicine, Hammersmith Hospital, London
T. J. Crow
Affiliation:
Division of Psychiatry, Clinical Research Centre, Harrow and the Endocrine Unit, Department of Medicine, Hammersmith Hospital, London
K. Mashiter
Affiliation:
Division of Psychiatry, Clinical Research Centre, Harrow and the Endocrine Unit, Department of Medicine, Hammersmith Hospital, London
*
1Address for correspondence: Dr Eve C. Johnstone, Division of Psychiatry, Clinical Research Centre, Watford Road, Harrow, Middlesex HA1 3UJ
Get access Rights & Permissions [Opens in a new window]

Synopsis

Prolactin, FSH, LH and TSH were determined in repeated samples of serum from 16 unmedicated male patients with chronic schizophrenia. Changes in the mental states between the 2 occasions were related to changes in hormone levels. Significant inverse correlations were established between prolactin and incoherence of speech, between prolactin and total positive symptoms and between FSH and poverty of speech. A significant positive correlation was established between FSH and delusions. These findings are discussed in the context of evidence concerning the role of monoamines in the control of anterior pituitary function, and of the dopamine and other monoamine hypotheses of schizophrenia. Although prolactin secretion was not as low, as would be predicted on the basis of the dopamine overactivity hypothesis of schizophrenia, the relationship between symptom change and change in prolactin secretion was consistent with the hypothesis that increasing symptom severity is associated with increasing dopamine release from the tubero-infundibular system.

Type
Research Article
Information
Psychological Medicine , Volume 7 , Issue 2 , May 1977 , pp. 223 - 228
Copyright
Copyright © Cambridge University Press 1977

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Beumont, P. S. V., Corker, C.S., Friesen, H. G., Kolakowska, T., Mandelbrote, B. M., Marshall, J., Murray, M. A. F. & Wiles, D. H. (1974). The effects of phenothiazines on endocrine function: II. Effects in men and post-meno-pausal women. British Journal of Psychiatry 124, 420–430.CrossRefGoogle ScholarPubMed
Bleuler, M. (1954). Endokrinologische Psychiatric Thieme: Stuttgart.Google Scholar
Bowers, M. B. (1974). Central dopamine turnover in schizophrenic syndromes. Archives of General Psychiatry 31, 50–54.CrossRefGoogle ScholarPubMed
Brambilla, F., Guerrini, A., Guastalla, A., Rovere, C. & Riggi, F. (1975). Neuroendocrine effects of haloperidol therapy in chronic schizophrenia. Psychopharmacologia (Berlin) 44, 17–22.CrossRefGoogle ScholarPubMed
Dahlström, A. & Fuxe, K. (1964). Evidence for the existence of monoamine containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiologica Scandinavica 62, Supplement 232, 1–55.Google Scholar
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G. & Miroz, R. (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26, 57–63.CrossRefGoogle ScholarPubMed
Fuxe, K. & Hökfelt, T. (1967). The influence of central catecholamine neurons on the hormone secretion from the anterior and posterior pituitary. In Neurosecretion (ed. Stutinsky, F.), pp. 166–177. IVth International Symposium on Neurosecretion.Google Scholar
Fuxe, K., Hökfelt, T. & Nilsson, O. (1969). Factors involved in the control of the activity of the tubero-infundibular dopamine neurons during pregnancy and lactation. Neuroendocrinologv 5, 257–270.CrossRefGoogle ScholarPubMed
Harsoulis, P., Marshall, L. C., Kuku, S. F., Burke, C. W., London, D. R. & Fraser, T. R. (1973). Combined test for assessment of anterior pituitary function. British Medical Journal iv, 326–329.CrossRefGoogle Scholar
Hills, M. (1969). On looking at large correlation matrices. Biometrika 56, 249–254.CrossRefGoogle Scholar
Hökfelt, T. & Fuxe, K. (1972). Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine neurons. Neuroendocrinology 9, 100–122.CrossRefGoogle Scholar
Horn, A. S. & Snyder, S. H. (1971). Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proceedings of the National Academy of Sciences 68, 2325–2328.CrossRefGoogle ScholarPubMed
Klawans, H. L., Goetz, C. & Westheimer, R. (1972). Pathophysiology of schizophrenia and the striatum. Diseases of the Nervous System 33, 711–719.Google ScholarPubMed
Kolakowska, T., Wiles, D. H., McNeilly, A. S. & Gelder, M. G. (1975). Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients. Psychological Medicine 5, 214–216.CrossRefGoogle ScholarPubMed
Krawiecka, M., Goldberg, D. P. & Vaughan, M. (1977). A standardised psychiatric assessment scale for rating chronic psychotic patients. (In preparation.)Google Scholar
McNeilly, A. S., Sturdy, J., Evans, D. G. & Chard, T. (1974). Short term variation in blood levels of prolactin, luteinising hormone and follicle stimulating hormone in normal men throughout the day. Journal of Endocrinology 61, 301–302.CrossRefGoogle ScholarPubMed
Marshall, J. C., Anderson, D. C., Burke, C. W., Galveo Teles, A. & Fraser, T. R. (1972). Clomiphene citrate in men: increase in Cortisol, luteinizing hormone, testosterone and steroid binding globulins. Journal of Endocrinology 53, 261–276.CrossRefGoogle ScholarPubMed
Marshall, J. C., Anderson, D. C., Fraser, T. R. & Harsoulis, P. (1973). Human luteinizing hormone in man: studies of metabolism and biological action. Journal of Endocrinology 56, 431–439.CrossRefGoogle ScholarPubMed
Matthysse, S. (1973). Antipsychotic drug actions, a clue to the neuropathology of schizophrenia? Federation Proceedings 32, 200–205.Google Scholar
Meltzer, H. Y., Sachar, E. J. & Frantz, A. G. (1974). Serum prolactin levels in unmedicated schizophrenic patients. Archives of General Psychiatry 31, 564–569.CrossRefGoogle ScholarPubMed
Miller, R. J., Horn, A. S. & Iversen, L. L. (1974). The action of neuroleptic drugs on dopamine-stimulated adenosine cyclic 3′, 5′-monophosphate production in rat neostriatum and limbic forebrain. Molecular Pharmacology 10, 759–766.Google Scholar
Noel, G. L., Suh, H. K., Stone, G. & Frantz, A. G. (1972). Human prolactin and growth hormone release during surgery and other conditions of stress. Journal of Clinical Endocrinology and Metabolism 35, 840–851.CrossRefGoogle ScholarPubMed
Randrup, A. & Munkvad, I. (1972). Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain. Orthomolecular Psychiatry 1, 2–7.Google Scholar
Sachar, E. J., Finkelstein, J. & Hellman, L. (1971). Growth hormone responses in depressive illness. Archives of General Psychiatry 25, 263–269.CrossRefGoogle Scholar
Sachar, E. J., Mushrush, G., Perlow, M., Weitzman, E. D. & Sassin, J. (1972). Growth hormone responses to L-dopa in depressed patients. Science 178, 1304–1305.CrossRefGoogle ScholarPubMed
Sachar, E. J., Halpern, F. S., Rosenfield, R. S., Gallagher, T. F. & Hellman, L. (1973 a). Plasma and urinary testosterone levels in depressed men. Archives of General Psychiatry 28, 15–18.CrossRefGoogle ScholarPubMed
Sachar, E. J., Hellmann, L., Roffwarg, H., Halpern, F. S., Fukushima, D. K. & Gallacher, T. F. (1973 b). Disrupted 24-hour patterns of Cortisol secretion in psychotic depression. Archives of General Psychiatry 28, 19–24.CrossRefGoogle ScholarPubMed
Snyder, S. H., Banerjee, S. P., Yamamura, H. I. & Greenberg, D. (1974). Drugs, neurotransmitters and schizophrenia. Science 184, 1243–1253.CrossRefGoogle ScholarPubMed
Stein, L. & Wise, C. D. (1971). Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science 171, 1032–1036.CrossRefGoogle Scholar
Stevens, J. R. (1973). An anatomy of schizophrenia. Archives of General Psychiatry 29, 177–189.CrossRefGoogle ScholarPubMed
Van Rossum, J. M. (1966). The significance of dopamine receptor blockade for the mechanism of action of neuroleptic drugs. Archives Internationales de Pharmacodynamie et de Thérapie 160, 492–494.Google ScholarPubMed